Clinical management of patients with primary immunodeficiencies during the COVID-19 pandemic
Isabella Quinti, Ivano Mezzaroma, Cinzia Milito
Abstract
: Surprisingly, a low number of IEI patients affected by SARS-Cov-2 were reported with a risk to die for COVID-19 overlapping that of the general population. The low number might be explained by the choice of most physicians to inform early in the pandemic about safety measures, to switch most of the IEI patients to home therapy and to remote assistance. The guidelines issued by the scientific societies and periodically updated, represent the best tool for the clinical management of IEI patients.
Topics & Concepts
MedicinePandemicCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicinePediatricsImmunologyVirologyOutbreakInternal medicineDiseaseInfectious disease (medical specialty)Immunodeficiency and Autoimmune DisordersImmune responses and vaccinationsCOVID-19 Clinical Research Studies